DK1690549T3 - Immunoterapeutisk middel, som anvendes til den kombinerede behandling af tuberkulose sammen med andre lægemidler - Google Patents
Immunoterapeutisk middel, som anvendes til den kombinerede behandling af tuberkulose sammen med andre lægemidlerInfo
- Publication number
- DK1690549T3 DK1690549T3 DK04791401T DK04791401T DK1690549T3 DK 1690549 T3 DK1690549 T3 DK 1690549T3 DK 04791401 T DK04791401 T DK 04791401T DK 04791401 T DK04791401 T DK 04791401T DK 1690549 T3 DK1690549 T3 DK 1690549T3
- Authority
- DK
- Denmark
- Prior art keywords
- tuberculosis
- drugs
- combined treatment
- immunotherapeutic agent
- agent used
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000002955 immunomodulating agent Substances 0.000 title abstract 2
- 201000008827 tuberculosis Diseases 0.000 title abstract 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 abstract 1
- 210000002421 cell wall Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200302551A ES2231037B1 (es) | 2003-10-31 | 2003-10-31 | Agente inmunoterapico util para el tratamiento combinado de la tuberculosis en asociacion con otros farmacos. |
| PCT/ES2004/000482 WO2005042013A1 (es) | 2003-10-31 | 2004-10-29 | Agente immunoterápico útil para el tratamento combinado de la tuberculosis en associación con otros fármacos |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1690549T3 true DK1690549T3 (da) | 2009-08-17 |
Family
ID=34530979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04791401T DK1690549T3 (da) | 2003-10-31 | 2004-10-29 | Immunoterapeutisk middel, som anvendes til den kombinerede behandling af tuberkulose sammen med andre lægemidler |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8246944B2 (da) |
| EP (1) | EP1690549B1 (da) |
| JP (1) | JP4998988B2 (da) |
| KR (1) | KR101146469B1 (da) |
| CN (1) | CN100490894C (da) |
| AT (1) | ATE428442T1 (da) |
| AU (1) | AU2004285305B2 (da) |
| BR (1) | BRPI0415695B8 (da) |
| CA (1) | CA2543659C (da) |
| DE (1) | DE602004020663D1 (da) |
| DK (1) | DK1690549T3 (da) |
| ES (2) | ES2231037B1 (da) |
| HK (1) | HK1098362A1 (da) |
| IL (1) | IL175030A (da) |
| MA (1) | MA28121A1 (da) |
| NZ (1) | NZ546715A (da) |
| PL (1) | PL1690549T3 (da) |
| PT (1) | PT1690549E (da) |
| RU (1) | RU2341287C2 (da) |
| WO (1) | WO2005042013A1 (da) |
| ZA (1) | ZA200604234B (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2231037B1 (es) | 2003-10-31 | 2005-12-16 | Archivel Technologies, Sl | Agente inmunoterapico util para el tratamiento combinado de la tuberculosis en asociacion con otros farmacos. |
| JPWO2007132790A1 (ja) * | 2006-05-12 | 2009-09-24 | 国立大学法人 北海道大学 | 細菌菌体成分を含む脂質膜を有するリポソーム |
| ES2307402B1 (es) * | 2006-10-30 | 2009-09-30 | Archivel Farma, S.L. | Vacuna profilactica contra la tuberculosis. |
| ES2335177B1 (es) * | 2008-09-19 | 2011-02-28 | Archivel Farma, S.L. | Agente inmunoterapeutico apropiado para la profilaxis primaria de la tuberculosis. |
| LT2661253T (lt) * | 2011-01-04 | 2017-05-25 | Archivel Farma, Sl | Liposomų kompozicija, tinkama tuberkuliozės gydymui arba prevencijai |
| EP2471511A1 (en) | 2011-01-04 | 2012-07-04 | Archivel Farma, SL | Liposome formulation suitable for treating or preventing tuberculosis |
| PT2802345T (pt) * | 2012-01-12 | 2018-04-24 | Archivel Farma Sl | Vacina mtb-c contra a asma |
| ES2758400B2 (es) | 2018-11-02 | 2021-01-20 | Univ Granada | Nanoparticulas biomimeticas mediadas por mamc |
| WO2023062066A1 (en) | 2021-10-14 | 2023-04-20 | Archivel Farma, S.L. | Liposome formulations for treatment of active tuberculosis |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3125598A1 (de) * | 1981-06-30 | 1983-01-13 | Mahle Gmbh, 7000 Stuttgart | Einrichtung zur druckbeaufschlagung des presszylinders einer druckgiessmaschine |
| JPS59161320A (ja) * | 1983-03-04 | 1984-09-12 | Maruyama Chisato | リポ多糖体およびその製造法 |
| GB8404280D0 (en) | 1984-02-17 | 1984-03-21 | Stanford J L | Biological preparations |
| JPS624701A (ja) * | 1985-06-29 | 1987-01-10 | Maruyama Chisato | リポ多糖体及びその製造法 |
| US4744984A (en) * | 1985-10-08 | 1988-05-17 | Vetrepharm Research, Inc. | Antiviral immunotherapeutic agent and preparation thereof |
| US5542935A (en) * | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
| US6641814B1 (en) * | 1997-04-02 | 2003-11-04 | Statens Serum Institut | Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis |
| US5785975A (en) * | 1995-06-26 | 1998-07-28 | Research Triangle Pharmaceuticals | Adjuvant compositions and vaccine formulations comprising same |
| US6284255B1 (en) | 1996-08-29 | 2001-09-04 | Genesis Research & Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US6982085B2 (en) * | 1997-04-02 | 2006-01-03 | Statens Serum Institut | TB diagnostic based on antigens from M. tuberculosis |
| WO2000021983A2 (en) * | 1998-10-08 | 2000-04-20 | Statens Serum Institut | Tuberculosis vaccine and diagnostic reagents based on antigens from the mycobacterium tuberculosis cell |
| RU2153354C1 (ru) * | 1999-03-31 | 2000-07-27 | Московский городской научно-практический центр борьбы с туберкулезом | Вакцина против туберкулеза |
| AU2002239485A1 (en) * | 2000-12-08 | 2002-06-18 | The Johns Hopkins University | Methods for improved diagnosis and treatment of mycobacterial infections |
| US7105170B2 (en) * | 2001-01-08 | 2006-09-12 | The United States Of America As Represented By The Department Of Health And Human Services | Latent human tuberculosis model, diagnostic antigens, and methods of use |
| AU2002254206A1 (en) * | 2001-03-16 | 2002-10-03 | Sarawak Medichem Pharmaceuticals, Inc. | Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity |
| AU2002314358C1 (en) | 2001-07-04 | 2009-03-26 | The Secretary Of State For Health | Mycobacterial antigens expressed during latency |
| WO2003018053A1 (en) | 2001-08-22 | 2003-03-06 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Vaccine against mycobacterial-induced diseases |
| BR0307262A (pt) | 2002-01-29 | 2006-12-19 | Bakulesh Mafatlal Khamar | método de prover profilaxia para tuberculose em indivìduos hiv positivos |
| ES2231037B1 (es) | 2003-10-31 | 2005-12-16 | Archivel Technologies, Sl | Agente inmunoterapico util para el tratamiento combinado de la tuberculosis en asociacion con otros farmacos. |
| DE102004053141A1 (de) * | 2004-11-03 | 2006-05-04 | Schülke & Mayr GmbH | Desinfektionsmittel mit verbesserter Wirksamkeit gegen Mykobakterien |
-
2003
- 2003-10-31 ES ES200302551A patent/ES2231037B1/es not_active Expired - Fee Related
-
2004
- 2004-10-29 DK DK04791401T patent/DK1690549T3/da active
- 2004-10-29 KR KR1020067008014A patent/KR101146469B1/ko active IP Right Grant
- 2004-10-29 CA CA2543659A patent/CA2543659C/en active Active
- 2004-10-29 EP EP04791401A patent/EP1690549B1/en active Active
- 2004-10-29 WO PCT/ES2004/000482 patent/WO2005042013A1/es active Application Filing
- 2004-10-29 US US10/577,840 patent/US8246944B2/en active Active
- 2004-10-29 AU AU2004285305A patent/AU2004285305B2/en not_active Ceased
- 2004-10-29 DE DE602004020663T patent/DE602004020663D1/de active Active
- 2004-10-29 PL PL04791401T patent/PL1690549T3/pl unknown
- 2004-10-29 AT AT04791401T patent/ATE428442T1/de not_active IP Right Cessation
- 2004-10-29 JP JP2006537326A patent/JP4998988B2/ja not_active Expired - Fee Related
- 2004-10-29 RU RU2006118795/13A patent/RU2341287C2/ru active
- 2004-10-29 BR BRPI0415695A patent/BRPI0415695B8/pt active IP Right Grant
- 2004-10-29 PT PT04791401T patent/PT1690549E/pt unknown
- 2004-10-29 NZ NZ546715A patent/NZ546715A/en unknown
- 2004-10-29 CN CNB2004800322762A patent/CN100490894C/zh active Active
- 2004-10-29 ES ES04791401T patent/ES2325835T3/es active Active
-
2006
- 2006-04-20 IL IL175030A patent/IL175030A/en active IP Right Grant
- 2006-04-28 MA MA28985A patent/MA28121A1/fr unknown
- 2006-05-25 ZA ZA200604234A patent/ZA200604234B/en unknown
-
2007
- 2007-05-04 HK HK07104774.7A patent/HK1098362A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1098362A1 (en) | Immunotherapic agent which is used for the combined treatment of tuberculosis togetheir with other pharmaceuticals | |
| WO2007030810A3 (en) | Multiparameter whole blood monitor and method | |
| SE0301700D0 (sv) | Novel compounds | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| EA200501702A1 (ru) | Устойчивая к манипуляциям дозировочная форма для трансдермального введения | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| NO20064547L (no) | Fremgangsmater for behandling av HIV infeksjon | |
| NO20050795L (no) | Forbindelser, blandinger og fremgangsmater for utnyttelse av samme | |
| WO2007087548A3 (en) | Chemical compounds | |
| DE60331236D1 (de) | Orale zusammensetzungen zur behandlung von diabetes | |
| NO20081844L (no) | Terapeutiske forbindelser | |
| NO20064584L (no) | Tetrahydropyridoindolderivater | |
| DK1730147T3 (da) | Substituerede 1,4,8-triazaspiro[4.5]decan-2-on-forbindelser til behandling af fedme | |
| AR039644A1 (es) | Composicion farmaceutica que comprende un androgeno, un mejorador de hsieh y un agente espesante. | |
| NO20062605L (no) | Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper | |
| NO20091955L (no) | Antivirale sammensetninger, og fremgangsmater for anvendelse | |
| PL376176A1 (en) | Solid preparation | |
| SE0302546D0 (sv) | New compounds | |
| PT1358177E (pt) | Tratamento de desordens afectivas atraves da accao combinada de um agonista do receptor nicotinico e uma substancia manoaminergica | |
| NO20073813L (no) | Kladribinregime for behandling av multippel sklerose | |
| WO2007110709A8 (en) | Formulations of tipifarnib for intravenous administration | |
| WO2004014367A3 (en) | Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer's disease | |
| DK1660115T3 (da) | Farmaceutisk kombination af G-CSF og PLGF anvendelig til blodstamceller | |
| NO20054346L (no) | Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander | |
| UA107177C2 (uk) | Імуногенна композиція цвс2 та спосіб приготування такої композиції |